Actuate director granted 15,000 stock options
ACTUATE THERAPEUTICS, INC. director and ten percent owner Aaron G.L.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACTUATE THERAPEUTICS, INC. director and ten percent owner Aaron G.L. Fletcher received a grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $2.4200 per share, expire on May 21, 2036, and will vest in full on the first anniversary of the grant date. Following this grant, Fletcher holds 15,000 stock options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 15,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Options will vest in full on the anniversary of the grant date.
Key Figures
Key Terms
Stock Options financial
exercise price financial
expiration date financial
vesting financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ACTU (Actuate Therapeutics) insider Aaron G.L. Fletcher report on this Form 4?
How many ACTU stock options were granted to Aaron G.L. Fletcher?
What is the exercise price of Aaron G.L. Fletcher’s ACTU stock options?
When do Aaron G.L. Fletcher’s ACTU stock options expire?
How and when do Aaron G.L. Fletcher’s ACTU stock options vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.